Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP631486.RAqk9Aavr1lGJF-x-JSIcmEd7x2SzvDfo7_K2yIlOSFlA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP631486.RAqk9Aavr1lGJF-x-JSIcmEd7x2SzvDfo7_K2yIlOSFlA130_assertion type Assertion NP631486.RAqk9Aavr1lGJF-x-JSIcmEd7x2SzvDfo7_K2yIlOSFlA130_head.
- NP631486.RAqk9Aavr1lGJF-x-JSIcmEd7x2SzvDfo7_K2yIlOSFlA130_assertion description "[The downregulated miRNAs include several with proven target mRNAs whose proteins have been previously shown to be increased in prostate cancer by immunohistochemistry, including RAS, E2F3, BCL-2 and MCL-1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP631486.RAqk9Aavr1lGJF-x-JSIcmEd7x2SzvDfo7_K2yIlOSFlA130_provenance.
- NP631486.RAqk9Aavr1lGJF-x-JSIcmEd7x2SzvDfo7_K2yIlOSFlA130_assertion evidence source_evidence_literature NP631486.RAqk9Aavr1lGJF-x-JSIcmEd7x2SzvDfo7_K2yIlOSFlA130_provenance.
- NP631486.RAqk9Aavr1lGJF-x-JSIcmEd7x2SzvDfo7_K2yIlOSFlA130_assertion SIO_000772 17891175 NP631486.RAqk9Aavr1lGJF-x-JSIcmEd7x2SzvDfo7_K2yIlOSFlA130_provenance.
- NP631486.RAqk9Aavr1lGJF-x-JSIcmEd7x2SzvDfo7_K2yIlOSFlA130_assertion wasDerivedFrom befree-2016 NP631486.RAqk9Aavr1lGJF-x-JSIcmEd7x2SzvDfo7_K2yIlOSFlA130_provenance.
- NP631486.RAqk9Aavr1lGJF-x-JSIcmEd7x2SzvDfo7_K2yIlOSFlA130_assertion wasGeneratedBy ECO_0000203 NP631486.RAqk9Aavr1lGJF-x-JSIcmEd7x2SzvDfo7_K2yIlOSFlA130_provenance.